Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0XOD stock hub

LON/0XOD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0XODis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.1B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0XOD
In the news

Latest news · LON/0XOD

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC-88.6
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0XOD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
167
Groups with data
11
Currency
USD
Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Israel
Country code
UK
Employees
291
Employees Change
70%
Employees Change Percent
32.26
Enterprise value
$1.1B
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Isin
IL0011407140
Last refreshed
2026-05-10
Market cap
$1.1B
Price
$29.67
Price currency
USD
Rev Per Employee
357,033.73x
Sic
2836
Symbol
lon/0XOD
Website
https://www.urogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-9.6%
EV Earnings
-10.83x
EV/FCF
-8.69x
EV/Sales
10.6x
FCF yield
-11.96%
P/B ratio
-11.17x
P/S ratio
9.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
EBIT Margin
-77.02%
EBITDA Margin
-76.8%
Gross margin
89.85%
Gross Profit
$95.6M
Gross Profit Growth
53.22%
Gross Profit Growth Q
161.21%
Gross Profit Growth3 Y
28.43%
Gross Profit Growth5 Y
48.67%
Net Income
$-100.9M
Pretax Margin
-98.45%
Profit Margin
-94.83%
Profit Per Employee
$-338,564
ROA
-26.98
Roa5y
-34.08
ROCE
-53.29
ROIC
-88.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
155.84%
Cagr3y
29.58%
Cagr5y
7.67%
Revenue Growth
52.92x
Revenue Growth Q
151.6x
Revenue Growth3 Y
27.37x
Revenue Growth5 Y
48.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
$0.56
Assets
$192.1M
Cash
$106.2M
Current Assets
$174.2M
Current Liabilities
$37.1M
Debt
$149.3M
Debt FCF
$-1.19
Equity
$-94.1M
Interest Coverage
-7
Liabilities
$286.2M
Long Term Assets
$17.9M
Long Term Liabilities
$249.1M
Net Cash
$-43M
Net Cash By Market Cap
$-4.09
Tangible Book Value
$-94.1M
Tangible Book Value Per Share
$-1.93
WACC
11.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.69
Inventory Turnover
1
Net Working Capital
$36.7M
Quick ratio
3.86
Working Capital
$141.5M
Working Capital Turnover
$0.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-7.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
155.67%
200-day SMA
20.61
3Y total return
117.63%
50-day SMA
20.84
50-day SMA vs 200-day SMA
50over200
5Y total return
44.72%
All Time High
51.66
All Time High Change
-49.83%
All Time High Date
2019-01-04
All Time Low
3.61
All Time Low Change
618.01%
All Time Low Date
2025-05-30
ATR
1.78
Beta
1.44
Ch YTD
12.99
High
30.33
High52
30.33
High52 Date
2026-05-08
High52ch
-2.16%
Low
26.59
Low52
3.61
Low52 Date
2025-05-30
Low52ch
721.88%
Ma50ch
24.37%
Price vs 200-day SMA
25.78%
RSI
73.92
RSI Monthly
62.48
RSI Weekly
69.5
Sharpe ratio
1.44x
Sortino ratio
2.33
Total Return
-7.34%
Tr YTD
12.99
Tr1m
44.32%
Tr1w
12.26%
Tr3m
21.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
$-81.9M
Operating margin
-77.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
38,698,096%
Net Borrowing
46,336,079.4
Shares Insiders
2.06%
Shares Institutions
78.95%
Shares Qo Q
1.93%
Shares Yo Y
7.34%
Short Ratio
9.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Adjusted FCF
$-136M
Average Volume
1,173.5x
Bv Per Share
-1.93
CAPEX
$-226,434
Ch1m
44.32
Ch1w
12.26
Ch1y
155.7
Ch3m
21.61
Ch3y
117.6
Ch5y
44.72
Ch6m
16.45
Change
14.47%
Change From Open
9.28
Close
25.92
Days Gap
4.75
Depreciation Amortization
227,389.3
Dollar Volume
105,803.2
Earnings Date
2026-05-06
EBIT
$-81.9M
EBITDA
$-81.7M
EPS
$-2.07
F Score
2
FCF
$-125.7M
FCF EV Yield
-11.5x
Financing CF
79,583,668
Fiscal Year End
December
Founded
2,004
Income Tax
$-3.9M
Investing CF
50,612,965
Is Primary Listing
0
Last Earnings Date
2026-05-06
Last Report Date
2026-03-31
Ma150
21.16
Ma150ch
22.48%
Ma20
23.84
Ma20ch
8.73%
Net CF
4,683,931
Next Earnings Date
2026-05-11
Open
27.15
Position In Range
82.46
Ppne
6,275,945.8
Price Date
2026-05-08
Relative Volume
3.04x
Revenue
106,396,051x
SBC By Revenue
9.62x
Share Based Comp
10,236,492
Tax By Revenue
-3.62x
Tr6m
16.45%
Volume
3,566
Z Score
-4.11
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0XOD pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0XOD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+155.7%
S&P 500 1Y: n/a
3Y total return
+117.6%
S&P 500 3Y: n/a
5Y total return
+44.7%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0XOD?

Insider, institutional, and short-interest positioning.

Institutional ownership
+78.9%
Share of float held by funds and institutions
Insider ownership
+2.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
9.2 days to cover
Y/Y dilution
+7.3%
Negative means the company is buying back shares.
Technical

LON/0XOD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
73.9
Above 70: short-term overbought
Price vs 200-day MA
+25.8%
50/200-day relationship not available
Beta (5Y)
1.44
More volatile than the market
Sharpe ratio
1.44
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0XOD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0XOD stock rating?

lon/0XOD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0XOD analysis?

The full report lives at /stocks/lon/0XOD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0XOD?

The latest report frames lon/0XOD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0XOD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.